Country
Germany
Early clinical data on a new cell therapy product to prevent organ rejection were reviewed in The Journal of Clinical Investigation on 1 May 2020 after a Phase 1b study showed the procedure to be safe and feasible.
Full text available to subscribers only. Click here for information on subscribing to MedNous.